ABSTRACT: The first β-lactone synthetase enzyme is reported, creating an unexpected link between the biosynthesis of olefinic hydrocarbons and highly functionalized natural products. The enzyme OleC, involved in the microbial biosynthesis of long-chain olefinic hydrocarbons, reacts with syn-and anti-β-hydroxy acid substrates to yield cis-and trans-β-lactones, respectively. Protein sequence comparisons reveal that enzymes homologous to OleC are encoded in natural product gene clusters that generate β-lactone rings, suggesting a common mechanism of biosynthesis.
T he β-lactone (2-oxetanone) substructure is well-known in organic synthesis and microbial natural products, some of which are presently being investigated for anti-obesity, anticancer, and antibiotic properties. 1−5 Although multiple organic synthesis routes exist for β-lactones, 6 no specific enzyme that catalyzes the formation of this functional group had been identified. While defining the chemistry of a wellknown olefinic hydrocarbon biosynthesis pathway, we identified a β-lactone synthetase whose presence extends into natural product biosynthesis.
The olefin biosynthesis pathway is encoded by a four-gene cluster, oleABCD, and is found in more than 250 divergent bacteria. 7 Ole enzymes produce long-chain hydrocarbon cisalkenes from activated fatty acids through the reported chemistry shown in Figure 1 . 8, 9 OleA, the first enzyme of the pathway, has been studied in Xanthomonas campestris (Xc) and found to catalyze the "head-to-head" coupling of CoA-activated fatty acids (1) to unstable β-keto acids (2) . 10 The second enzyme, OleD, couples the reduction of 2 with NADPH oxidation to yield stable β-hydroxy acids (3) as defined in Stenotrophomonas maltophilia (Sm). 11 Finally, using gas chromatography (GC) detection methods, we have observed and others have reported that Sm OleC catalyzes an apparent decarboxylative dehydration reaction to generate the final cisolefin product. 12 Together, these findings indicate that there is no defined purpose for the ever-present fourth gene in the cluster, oleB.
We now report that the observation of cis-alkenes as products of OleC is an artifact, a misleading observation caused by GC analytical methods used to identify the high-boiling point products of OleC. Rather, using 1 H nuclear magnetic resonance (NMR), we demonstrate that OleC proteins from four different bacteria produce thermally labile β-lactones from β-hydroxy acids in an ATP-dependent reaction; no alkenes are observed. Further analyses of gene clusters for β-lactone-containing natural products reveal oleC homologues that likely perform this previously unknown biological β-lactone ring closure reaction.
The first suggestions of β-lactone synthetase activity arose when monitoring reactions of Xc OleC with ATP, MgCl 2 , and a synthetic, diastereomeric mixture of 3 by GC. Full 1 H NMR spectra of all synthesized compounds from this study are shown in Figures S1−S6. Two peaks were observed by GC, coupled to both a mass spectrometer and flame ionization detector (FID), with mass spectra and retention times identical to those of synthetic cis-and trans-olefin standards (5a and 5b, respectively). However, the GC/FID peak area of the enzymatically generated olefin varied significantly with GC inlet temperature and inlet liner purity, while synthetic standards were unaffected, suggesting that the observed olefin may be a thermal decomposition product of the actual OleC product.
To test this hypothesis, reactions of Xc OleC with 3 were scaled to generate sufficient quantities for 1 H NMR. No resonances consistent with the prepared olefin standards (Figures S1 and S2) (5a and 5b) were observed; rather, four distinct multiplets, each appearing as a doublet of doublets of doublets, arose ( Figures S7 and S8 ). These resonances were consistent with the two hydrogens of cis-and trans-β-lactone rings and perfectly matched our authentic standards of cis-and trans-3-octyl-4-nonyloxetan-2-one (4a and 4b, respectively) ( Figures S3 and S4 ). Furthermore, when 4a and 4b were analyzed by GC, retention times and mass spectra matched those of olefin standards 5a and 5b, with sensitivity to inlet conditions being observed. The thermal decarboxylation of cisand trans-β-lactone to cis-and trans-olefin, respectively, is wellknown. 13, 14 We believe that thermal decomposition during GC/mass spectrometry (MS) analysis caused the product of OleC catalysis to be misidentified. Additionally, when supplemental NMR data from the literature report of Sm OleC characterization were reviewed, resonances of the cis-and trans-β-lactones, consistent with those synthesized here, are visible. 12 The stereochemical origins of 4a and 4b were then investigated by reacting Xc OleC with syn-and anti-β-hydroxy acids ( Figures S9 and S10 ). High-performance liquid chromatography was used to separate 3 into its syn-and antidiastereomeric pairs (3a and 3b, respectively) ( Figure 2 ).
Examining 3a and 3b by 1 H NMR and GC/MS, postmethylation, demonstrated each contained <10% of the opposite racemic diastereomer ( Figures S5 and S6 ). When reacting with Xc OleC, 3a produced 4a while 3b generated 4b (Figure 3 ). GC/MS analysis supported this conclusion, as OleC reactions with 3a and 3b yielded the β-lactone breakdown products, 5a and 5b, respectively. OleC consumed >90% of substrates 3a and 3b as determined by GC/MS, supporting the conclusions of Kancharla et al. that all four β-hydroxy acid isomers are utilized by OleC. 12 Taken together, Xc OleC represents the first reported β-lactone synthetase, converting β-hydroxy acid substrates to β-lactones in the presence of ATP and MgCl 2 . MgATP is likely required to activate the hydroxyl or carboxyl group and promote β-lactone ring formation.
To determine if β-lactone synthetase activity is a common enzymatic step in long-chain olefin biosynthesis, we obtained four oleC genes from oleABCD gene clusters in divergent microorganisms (Table 1) . Purified OleC enzymes from the four organisms were reacted overnight with ATP, MgCl 2 , and 3 and then analyzed by 1 H NMR and GC/MS. The products of OleC proteins from the bacteria S. maltophilia, Arenimonas malthae, and Lysobacter dokdonensis were both 4a and 4b β-lactones (Figures S11−S13), with no 5a or 5b olefins being observed, indicating that OleC enzymes from diverse sources are β-lactone synthetases. The Gram-positive bacterium Micrococcus luteus (Ml) was specifically chosen because its sequence diverges greatly from that of Xc OleC, and it contains a natural fusion of the oleB and oleC genes. This natural oleBC fusion is found in actinobacteria, which comprise ∼30% of the microorganisms that contain identifiable oleABCD genes. Reaction of the purified Ml OleBC fusion with MgCl 2 , ATP, and 3 produced β-lactones 4a and 4b as well as small amounts of cis-olefin, 5a ( Figure S14 ). No trace of trans-olefin, 5b, was detected. Further characterization is ongoing, but we believe that OleB performs a syn elimination of carbon dioxide from the cis-β-lactone to form the final cis-olefin product. This is consistent with previous studies of microorganisms expressing ole genes that contain olefins with a cis relative configuration exclusively. 7−9 These data also demonstrate that an enzyme domain with an amino acid sequence only 35% identical to that of the Xc OleC generates β-lactones, indicating that this activity is likely common among all olefinic hydrocarbon biosynthesis OleC homologues. Establishing the widespread nature of lactone synthetase activity within olefinic hydrocarbon biosynthesis led us to search sequence databases for OleC homologues in other biosynthetic pathways. OleC is a member of the ubiquitous AMP-dependent ligase/synthetase enzyme superfamily; as such, homologues are found in all organisms. 15 As of November 2016, a BLAST search of NCBI's nonredundant protein sequence database identified more than 900 sequences with >35% sequence identity and more than 16000 with >25% sequence identity to Xc OleC.
Of the sequences examined, two Xc OleC homologues were clearly encoded in gene clusters known to produce β-lactone natural products (Figure 4 ). The first, LstC, is an uncharacterized enzyme found in the lipstatin biosynthesis pathway from Streptomyces toxytricini. Lipstatin is the precursor to Orlistat, the only over-the-counter, Food and Drug Administration-approved anti-obesity drug. LstC is a member of the AMP-dependent ligase/synthetase superfamily, and its protein sequence is 38% identical to that of Xc OleC, more similar than the sequence of the β-lactone synthetase domain of Ml OleBC (35%). Surprisingly, further investigation revealed homologues of OleA and OleD encoded by the lipstatin gene cluster, suggesting that the two gene clusters have a common ancestry. The syntheses of both lipstatin and olefinic hydrocarbons are initiated by the condensation of two fatty acylCoAs to form a β-keto acid. In the case of lipstatin, the two fatty acids are 3-hydroxy-linoleic and octanoic acid. 1 The hydroxyl group of linoleic acid is later functionalized by LstE and LstF with a modified valine. 1 LstD and OleD likely perform the same NADPH-dependent reduction of the β-keto group to a hydroxyl group. Formation of the trans-β-lactone is likely accomplished by the OleC homologue LstC, to generate the final product in lipstatin biosynthesis. Olefin biosynthesis is completed by the putative OleB-dependent elimination of CO 2 to generate the final olefin product. The lipstatin gene cluster lacks any gene product that is homologous to OleB, consistent with the accumulation of the β-lactone natural product and further supporting our hypothesis that OleB performs the final step in the biosynthetic pathway to olefins.
The gene cluster responsible for the biosynthesis of ebelactone A, a commercially available esterase inhibitor, in Streptomyces aburaviensis shows a gene, orf1, with an amino acid sequence 46% identical to that of Xc OleC and is directly adjacent to ebeA−G (Figure 4 ). Unlike lipstatin, ebelactone A is formed partly by a polyketide synthase multidomain protein rather than fatty acid condensation; as such, OleA and OleD homologues are not encoded in the surrounding gene cluster.
Literature reports suggest that the β-lactone ring of ebelactone A is formed spontaneously from the final, enzyme-linked, β-hydroxy-thioester intermediate. 5 While a spontaneous β-hydroxy-thioester cyclization is mechanistically plausible, β-lactone formation from β-hydroxy-thioesters in ubiquitous pathways such as fatty acid oxidation or synthesis has not been reported to the best of our knowledge. 16 Additionally, β-hydroxy-thioester intermediates are extremely common in polyketide synthesis pathways, while β-lactone formation is comparatively rare. An Orf1-independent cyclization would require a unique property of ebelactone A precursors or a novel polyketide domain architecture to promote β-lactone ring cyclization. However, in favor of an Orf1-independent mechanism is the fact that no thioesterase domain exists in the final polyketide synthesis domain, suggesting that no free β-hydroxy acid is released for the putative ATP-dependent Orf1 to act on. Other polyketide-type β-lactone gene clusters, such as those for salinosporamide A, cinnabaramide, and oxazolomycin, do not encode an OleC homologue with high sequence identity (>35%) in the vicinity of the cluster. Polyketide-derived β-lactones are thought to form by the cyclization of the final thioester, enzyme-linked intermediate, but this has never been characterized. 2,17−19 It is reasonable to hypothesize that specialized polyketide synthase domains represent a second mechanism of β-lactone formation. Regardless, the discovery of a stand-alone β-lactone synthetase here creates new opportunities for the natural product field. Preliminary screening of Streptomyces and Nocardia genomes suggests that β-lactone natural products may be more widespread than currently realized.
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.biochem.6b01199.
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